Literature Intelligence

Literature Intelligence is a GenAI-powered solution from ArisGlobal designed for medical literature intake and assessment. It is built to automate literature monitoring workflows for life sciences organizations, including biopharmaceutical companies, CROs, and regulatory bodies. The solution is system-agnostic, meaning it integrates with existing drug safety systems without requiring replacement of current infrastructure.

The tool targets teams responsible for literature screening and pharmacovigilance, aiming to reduce the time and manual effort involved in processing large volumes of medical literature while supporting compliance with global regulatory requirements.

Core Capabilities

• Automates end-to-end literature screening workflows using AI/ML and GenAI, reducing processing time from days to minutes.
• Performs automated de-duplication of literature records to minimize redundant data and manual review.
• Conducts ICSR (Individual Case Safety Report) relevancy assessment automatically to filter literature at scale.
• Integrates via API with global literature databases including PubMed, Medline, and Embase for automated literature ingestion.
• Supports integration with preferred full-text providers, enabling GenAI-assisted data extraction and analysis of full-text articles.
• Provides tailored workflows that can be configured to meet specific organizational needs while maintaining compliance with global regulatory standards.

Reported Benefits

• Reduces reliance on repetitive, labor-intensive manual screening processes.
• Aims to improve data accuracy by reducing human error, fatigue, and bias in literature assessment.
• Shifts team focus toward higher-value activities by automating routine literature management tasks.
• Offers a scalable cloud-based deployment model intended to lower total cost of ownership.

Integration and Interoperability

• Designed to be system-agnostic, supporting interoperability with existing safety systems without workflow disruption.
• Connects via API to major medical literature databases (PubMed, Medline, Embase) for continuous, automated data ingestion.
• Functions as a modular component within ArisGlobal's broader GenAI-powered safety solutions portfolio.

Literature Intelligence is delivered as a cloud solution and is part of ArisGlobal's LifeSphere technology platform. ArisGlobal works with more than 220 global life sciences companies and government health authorities, including the FDA, Health Canada, and NMPA, and maintains offices in the United States, Europe, India, Japan, and China.